Compounds > temozolomide
Page last updated: 2024-08-16

temozolomide and abt-737

temozolomide has been researched along with abt-737 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooper, DA; Fujita, M; Goldstein, NB; Norris, DA; Partyka, KA; Reuland, SN; Shellman, YG1
Cheng, JT; Chou, AK; Chou, CH; Hong, YR; Howng, SL; Huang, WS; Li, YY; Lieu, AS; Loh, JK; Wang, YT; Yang, MC1
Johnston, G; Lincoln, FA; Murphy, BM; Noonan, J; Rehm, M; Weyhenmeyer, BC; Würstle, ML1

Other Studies

3 other study(ies) available for temozolomide and abt-737

ArticleYear
The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Alkylating Agents; Animals; Apoptosis; Biomimetic Materials; Biphenyl Compounds; Cell Line, Tumor; Dacarbazine; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Mice; Nitrophenols; Piperazines; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Temozolomide; Time Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2011
Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: a prospective combination of ABT-737 and TMZ for treating glioma.
    International journal of oncology, 2015, Volume: 46, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; bcl-X Protein; Biphenyl Compounds; Dacarbazine; Drug Resistance, Neoplasm; Glioma; Humans; Models, Molecular; Muscle Proteins; Nitrophenols; Peptide Fragments; Piperazines; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Temozolomide; Tumor Cells, Cultured

2015
Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.
    Oncotarget, 2016, Sep-20, Volume: 7, Issue:38

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Biphenyl Compounds; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Humans; Models, Theoretical; Nitrophenols; Piperazines; Signal Transduction; Sulfonamides; Systems Biology; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome

2016